Heath Jason Mark Ellison

Affiliations

  • Chief Development Officer at Opiant Pharmaceuticals Inc. (OPNT), 2023-03-03
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OPNT $20.26 610 Officer 18,751 2023-01-27 Filing
OPNT $20.20 469 Officer 19,361 2023-01-09 Filing
OPNT $20.20 1,806 Officer 19,830 2023-01-05 Filing